118 related articles for article (PubMed ID: 37910001)
21. Reducing NETO2 expression prevents human nasopharyngeal carcinoma (NPC) progression by suppressing metastasis and inducing apoptosis.
He AR; Zhu Q; Gao S
Biochem Biophys Res Commun; 2019 May; 513(2):494-501. PubMed ID: 30975469
[TBL] [Abstract][Full Text] [Related]
22. Reduction and Scavenging of Chemically Reactive Drug Metabolites by NAD(P)H:Quinone Oxidoreductase 1 and NRH:Quinone Oxidoreductase 2 and Variability in Hepatic Concentrations.
den Braver-Sewradj SP; den Braver MW; Toorneman RM; van Leeuwen S; Zhang Y; Dekker SJ; Vermeulen NPE; Commandeur JNM; Vos JC
Chem Res Toxicol; 2018 Feb; 31(2):116-126. PubMed ID: 29281794
[TBL] [Abstract][Full Text] [Related]
23. NAD(P)H:quinone oxidoreductase-1-dependent and -independent cytotoxicity of potent quinone Cdc25 phosphatase inhibitors.
Han Y; Shen H; Carr BI; Wipf P; Lazo JS; Pan SS
J Pharmacol Exp Ther; 2004 Apr; 309(1):64-70. PubMed ID: 14718602
[TBL] [Abstract][Full Text] [Related]
24. Antipsychotic drug trifluoperazine as a potential therapeutic agent against nasopharyngeal carcinoma.
Yeh CF; Lee WY; Yu TH; Hsu YB; Lan MC; Lan MY
Head Neck; 2023 Feb; 45(2):316-328. PubMed ID: 36349408
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of RKIP promotes radioresistance of nasopharyngeal carcinoma by activating NRF2/NQO1 axis via downregulating miR-450b-5p.
Huang W; Shi G; Yong Z; Li J; Qiu J; Cao Y; Zhao Y; Yuan L
Cell Death Dis; 2020 Jul; 11(7):504. PubMed ID: 32632129
[TBL] [Abstract][Full Text] [Related]
26. Anticancer targets and mechanisms of calycosin to treat nasopharyngeal carcinoma.
Liu F; Pan Q; Wang L; Yi S; Liu P; Huang W
Biofactors; 2020 Jul; 46(4):675-684. PubMed ID: 32449282
[TBL] [Abstract][Full Text] [Related]
27. NAD(P)H: quinone oxidoreductase 1 attenuates oxidative stress and apoptosis by regulating Sirt1 in diabetic nephropathy.
Qiu D; Song S; Wang Y; Bian Y; Wu M; Wu H; Shi Y; Duan H
J Transl Med; 2022 Jan; 20(1):44. PubMed ID: 35090502
[TBL] [Abstract][Full Text] [Related]
28. Cytotoxicity of RH1: NAD(P)H:quinone acceptor oxidoreductase (NQO1)-independent oxidative stress and apoptosis induction.
Tudor G; Alley M; Nelson CM; Huang R; Covell DG; Gutierrez P; Sausville EA
Anticancer Drugs; 2005 Apr; 16(4):381-91. PubMed ID: 15746574
[TBL] [Abstract][Full Text] [Related]
29. METCAM/MUC18 Plays a Tumor Suppressor Role in the Development of Nasopharyngeal Carcinoma Type I.
Liu YC; Chen YJ; Wu GJ
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362174
[TBL] [Abstract][Full Text] [Related]
30. P53 hot-spot mutants are resistant to ubiquitin-independent degradation by increased binding to NAD(P)H:quinone oxidoreductase 1.
Asher G; Lotem J; Tsvetkov P; Reiss V; Sachs L; Shaul Y
Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15065-70. PubMed ID: 14634213
[TBL] [Abstract][Full Text] [Related]
31. Chemical synthesis and biological evaluation of a NAD(P)H:quinone oxidoreductase-1 targeted tripartite quinone drug delivery system.
Volpato M; Abou-Zeid N; Tanner RW; Glassbrook LT; Taylor J; Stratford I; Loadman PM; Jaffar M; Phillips RM
Mol Cancer Ther; 2007 Dec; 6(12 Pt 1):3122-30. PubMed ID: 18089707
[TBL] [Abstract][Full Text] [Related]
32. Luteolin-7-O-glucoside inhibits cell proliferation and modulates apoptosis through the AKT signaling pathway in human nasopharyngeal carcinoma.
Ho HY; Chen PJ; Lo YS; Lin CC; Chuang YC; Hsieh MJ; Chen MK
Environ Toxicol; 2021 Oct; 36(10):2013-2024. PubMed ID: 34165247
[TBL] [Abstract][Full Text] [Related]
33. Silencing fibronectin extra domain A enhances radiosensitivity in nasopharyngeal carcinomas involving an FAK/Akt/JNK pathway.
Ou J; Pan F; Geng P; Wei X; Xie G; Deng J; Pang X; Liang H
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e685-91. PubMed ID: 22208970
[TBL] [Abstract][Full Text] [Related]
34. URG4-silencing suppresses cell proliferation in nasopharyngeal carcinoma through induction of apoptosis.
Luo XY; Yan B; Cai CF; Chen AM; Zhou M
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1717-1725. PubMed ID: 29630117
[TBL] [Abstract][Full Text] [Related]
35. Curcumin analogue T83 exhibits potent antitumor activity and induces radiosensitivity through inactivation of Jab1 in nasopharyngeal carcinoma.
Pan Y; Wang M; Bu X; Zuo Y; Wang S; Wang D; Liu Q; Su B; Xu T; Wang C; Claret FX; Yang H
BMC Cancer; 2013 Jul; 13():323. PubMed ID: 23815987
[TBL] [Abstract][Full Text] [Related]
36. NAD(P)H:quinone oxidoreductase 1 is induced by progesterone in cardiomyocytes.
Morrissy S; Strom J; Purdom-Dickinson S; Chen QM
Cardiovasc Toxicol; 2012 Jun; 12(2):108-14. PubMed ID: 21947872
[TBL] [Abstract][Full Text] [Related]
37. Caffeic acid phenethyl ester suppressed growth and metastasis of nasopharyngeal carcinoma cells by inactivating the NF-κB pathway.
Liang Y; Feng G; Wu L; Zhong S; Gao X; Tong Y; Cui W; Qin Y; Xu W; Xiao X; Zhang Z; Huang G; Zhou X
Drug Des Devel Ther; 2019; 13():1335-1345. PubMed ID: 31118570
[No Abstract] [Full Text] [Related]
38. Catalytic properties of NAD(P)H:quinone acceptor oxidoreductase: study involving mouse, rat, human, and mouse-rat chimeric enzymes.
Chen S; Knox R; Lewis AD; Friedlos F; Workman P; Deng PS; Fung M; Ebenstein D; Wu K; Tsai TM
Mol Pharmacol; 1995 May; 47(5):934-9. PubMed ID: 7746280
[TBL] [Abstract][Full Text] [Related]
39. Indigofera suffruticosa Mill extracts up-regulate the expression of the π class of glutathione S-transferase and NAD(P)H: quinone oxidoreductase 1 in rat Clone 9 liver cells.
Chen CC; Liu CS; Li CC; Tsai CW; Yao HT; Liu TC; Chen HW; Chen PY; Wu YL; Lii CK; Liu KL
Food Chem Toxicol; 2013 Sep; 59():610-7. PubMed ID: 23831193
[TBL] [Abstract][Full Text] [Related]
40. Antioxidant response induced by serum withdrawal protects HL-60 cells against inhibition of NAD(P)H:quinone oxidoreductase 1.
Gómez-Díaz C; Bello RI; López-Lluch G; Forthoffer N; Navas P; Villalba JM
Biofactors; 2003; 18(1-4):219-28. PubMed ID: 14695937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
